Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to 0.33.

  • Arcturus Therapeutics Holdings' Asset Utilization Ratio fell 2190.88% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 2190.88%. This contributed to the annual value of 0.39 for FY2024, which is 386.51% up from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Asset Utilization Ratio stood at 0.33 for Q3 2025, which was down 2190.88% from 0.38 recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Asset Utilization Ratio registered a high of 0.67 during Q3 2023, and its lowest value of 0.02 during Q2 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.38 (2023), whereas its average is 0.31.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Asset Utilization Ratio plummeted by 9238.97% in 2021 and then skyrocketed by 175348.87% in 2022.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Asset Utilization Ratio (Quarter) stood at 0.03 in 2021, then skyrocketed by 1753.49% to 0.55 in 2022, then crashed by 32.09% to 0.38 in 2023, then rose by 13.33% to 0.43 in 2024, then fell by 22.59% to 0.33 in 2025.
  • Its last three reported values are 0.33 in Q3 2025, 0.38 for Q2 2025, and 0.43 during Q1 2025.